CytoDyn Inc. ( CYDY) - Key Metrics
CYDY Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | $0 | $0 | $0 | $0 |
| 2026Q2 | $0 | -$0.02 | $0 | $0 |
| 2026Q1 | $0 | $0 | $0 | $0 |
| 2025Q4 | $0 | $0 | $0 | $0 |
| 2025Q3 | $0 | $0 | $0 | $0 |
CYDY Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | -7.76% | -15.62 |
| 2026Q2 | -1.63% | -4.53 |
| 2026Q1 | -6.73% | -15.95 |
| 2025Q4 | 0% | -16.61 |
| 2025Q3 | -7.67% | -18.28 |
CYDY Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q3 | -1.73% | 0.11% |
| 2026Q2 | -1.05% | 0.09% |
| 2026Q1 | -0.65% | 0.10% |
| 2025Q4 | -1.34% | 0% |
| 2025Q3 | -1.31% | 0.10% |
CYDY
Price: $0.19
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.03 USD
P/E Ratio: -7.82
Exchange: OQB
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 257.5 million